ClinCalc Pro
Menu
Insulin Pregnancy: B — insulin of choice in diabetes in pregnancy

Insulin (Soluble / Actrapid)

Brand names: Actrapid, Humulin S, NovoRapid (aspart), Novorapid

Adult dose

Dose: Sliding scale: 0–8 units SC based on capillary glucose. VRIII: 0–6 units/hr IV per local protocol
Route: Subcutaneous or Intravenous
Frequency: Per protocol
DKA: 0.1 unit/kg/hr IV infusion (after initial fluid resuscitation). HHS: lower doses. Hyperkalaemia: 10 units in 50mL 50% dextrose IV over 15min.

Paediatric dose

Dose: 0.1 units/hour/kg
Route: IV
DKA in children: 0.1 units/kg/hr after 1 hour of fluid resuscitation. Never bolus insulin in paediatric DKA.
Paediatric weight-based calculator

DKA in children: 0.1 units/kg/hr after 1 hour of fluid resuscitation. Never bolus insulin in paediatric DKA.

Clinical pearls

  • In DKA: start IV fluids FIRST, then insulin 1 hour later (prevents cerebral oedema risk)
  • Switch IV to SC insulin 30–60min BEFORE stopping IV infusion (prevent rebound hyperglycaemia)
  • Never use IM route routinely — unpredictable absorption
  • Insulin aspart/lispro/glulisine: rapid-acting analogues, onset 10–20min
  • Insulin glargine/detemir/degludec: basal insulins, 24h duration, no peak

Contraindications

  • Hypoglycaemia

Side effects

  • Hypoglycaemia
  • Hypokalaemia (IV use)
  • Injection site lipohypertrophy
  • Oedema on initiation
  • Weight gain

Interactions

  • Beta-blockers — mask hypoglycaemia symptoms (except sweating)
  • Salicylates, ACE inhibitors, MAOIs — potentiate hypoglycaemic effect

Monitoring

  • Capillary blood glucose (1-2 hourly in acute setting)
  • Serum potassium (IV use)
  • Ketones (DKA — aim for ketone clearance)
  • Bicarbonate (DKA)

Reference: BNFc; JBDS DKA Guidelines 2023; NICE NG17. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.